IP Library Granted Patent US 9,155,297
Granted Patent B2
US 9,155,297 · App. 14/316,257 · Granted Oct 13, 2015

Methods and systems for assessing the suitability of an organ for transplant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,155,297
App. No.
14/316,257
Granted
Oct 13, 2015
Kind
B2
Abstract

Methods of determining the health of an organ, such as a transplant organ, by measuring the ex-situ oxygen consumption rate of the organ. Systems for preserving and transporting organs while monitoring viability by measuring oxygen consumption rates.

Claims (20)

1. A method for evaluating the suitability of an organ for transplant, the method comprising:

inserting an organ into a mobile perfusion machine comprising:

a preservation solution; and

a pneumatic system configured to oxygenate the preservation solution to create an oxygenated solution, and further configured to vary a pressure of the oxygenated solution at least once per minute to create a differential perfusion pressure;

perfusing the organ with the oxygenated solution at a hypothermic temperature;

measuring the oxygen consumption rate of the organ;

comparing the measured oxygen consumption rate to a functional oxygen consumption rate wherein a measured oxygen consumption rate greater than or equal to the functional oxygen consumption rate is indicative of a suitable organ; and

using a processor to alter a perfusion property based on the comparison.

2. The method of claim 1 , wherein the differential perfusion pressure is greater than 0 mm Hg and less than or equal to 120 mm Hg.

3. The method of claim 2 , wherein the differential perfusion pressure is greater than 0 mm Hg and less than or equal to 50 mm Hg.

4. The method of claim 1 , wherein the functional oxygen consumption rate is greater than or equal to 50 nmolO 2 /min/g of organ mass.

5. The method of claim 1 , wherein the organ is selected from the group consisting of heart, kidney, liver, lung, and pancreas.

6. The method of claim 1 , wherein the organ is perfused at a temperature of less than 10° C.

7. The method of claim 1 , wherein the organ is from an expanded criteria donor (ECD) or from a donation after cardiac death (DCD).

8. The method of claim 1 , additionally comprising monitoring vascular resistance of the organ to perfusion.

9. The method of claim 1 , wherein the mobile perfusion machine varies the pressure on the oxygenated solution at least once every 10 seconds.

10. The method of claim 1 , wherein the mobile perfusion machine additionally comprises one or more oxygen sensors.

11. The method of claim 1 , wherein the mobile perfusion machine oxygenates the preservation solution with a partial pressure of oxygen of at least 100 mmHg (100 Torr).

12. The method of claim 11 , wherein the mobile perfusion machine displays a value indicative of the oxygen consumption rate of the organ.

13. The method of claim 1 , wherein the perfusion property is one selected from the list consisting of: perfusion temperature, flow rate, and pressure.

Assignments (4)
SECURITY INTEREST Recorded May 10, 2022
From: PARAGONIX TECHNOLOGIES, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 059878/0226 →
RELEASE OF SECURITY INTEREST Recorded Oct 7, 2021
From: CAMMETT, JOHN
To: PARAGONIX TECHNOLOGIES, INC.
Reel/Frame 057730/0972 →
SECURITY INTEREST Recorded Feb 18, 2016
From: PARAGONIX TECHNOLOGIES, INC.
To: CAMMETT, JOHN
Reel/Frame 037766/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2014
From: ANDERSON, LISA MARIA; JUDSON, JARED ALDEN
To: PARAGONIX TECHNOLOGIES, INC.
Reel/Frame 034454/0071 →